Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
fda
gene therapy
johnson & johnson
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
novartis
zolgensma
2
×
10x genomics
abbvie
achromatopsia
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
beta-thalassemia
bill cassidy
biogen
biotech
bluebird bio
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
dana hilt
What
past
2
×
age
august
bigger
biggest
bio
biotech
busy
come
days
deal
decisions
devices
drugs
emerging
fda
gave
gene
j
johnson
legacy
meiragtx
morning
news
nods
opioid
regulatory
roundup
sarepta’s
seven
shkreli’s
signal
signals
slow
stumble
suits
tends
therapy
won
years
Language
unset
Current search:
zolgensma
×
past
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy